Abstract
The possibility of reprogramming somatic cells into induced pluripotent stem cells (iPSCs), due to their ability to differentiate into tissues of the three embryonic layers, offers an unprecedented opportunity in translational and regenerative medicine, especially for neurological disorders. In this context, it is worth highlighting Alzheimer's Disease (AD), a neurodegenerative disorder t…